bosentan anhydrous has been researched along with enalapril in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Clozel, JP; Clozel, M; Gonzales, MF; Hess, P; Heudes, D; Karam, H; Löffler, BM | 1 |
Bruneval, P; Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM | 1 |
Clozel, JP; Clozel, M; Gonzales, MF; Heudes, D; Karam, H; Löffler, BM | 1 |
Stewart, DJ | 1 |
Teerlink, JR | 1 |
Clozel, M; Ding, SS; Hess, P; Qiu, C; Xi, JF; Zheng, N | 1 |
Banoglu, ZN; Dengiz, GO; Kandemir, NO; Kurcer, Z; Mungan, G; Ozacmak, VH; Turkili, B | 1 |
2 review(s) available for bosentan anhydrous and enalapril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Impact of endothelin-1 on vascular structure and function.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Enalapril; Endothelin-1; Humans; Hypertension; Muscle, Smooth, Vascular; Sulfonamides | 1998 |
11 other study(ies) available for bosentan anhydrous and enalapril
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bosentan; Calcium Channel Blockers; Cardiomegaly; Collagen; Coronary Circulation; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Fibrosis; Hypertension; Male; Mibefradil; Myocardium; Perfusion; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Body Weight; Bosentan; Calcium Channel Blockers; Cardiomegaly; Coronary Circulation; Enalapril; Endothelins; Fibrosis; Heart Ventricles; Hemodynamics; Hormones; Hypertension; Kidney; Mibefradil; Myocardium; Rats; Rats, Inbred SHR; Sulfonamides; Tetrahydronaphthalenes | 1996 |
Respective role of humoral factors and blood pressure in aortic remodeling of DOCA hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Benzimidazoles; Blood Pressure; Bosentan; Calcium Channel Blockers; Desoxycorticosterone; Enalapril; Endothelin Receptor Antagonists; Endothelins; Hypertension, Renovascular; Male; Mibefradil; Rats; Rats, Wistar; Sulfonamides; Tetrahydronaphthalenes; Tunica Media | 1996 |
Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bosentan; Clinical Trials as Topic; Enalapril; Endothelin Receptor Antagonists; Female; Heart Failure; Humans; Male; Metalloendopeptidases; Middle Aged; Neurotransmitter Agents; Pyridines; Sulfonamides; Thiazepines; Treatment Outcome | 2002 |
Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bosentan; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Endothelin A Receptor Antagonists; Glomerular Filtration Rate; Kidney; Male; Organ Size; Rats; Rats, Wistar; Sulfonamides; Vasoconstriction | 2003 |
Role of angiotensin and endothelin in testicular ischemia reperfusion injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Bosentan; Enalapril; Endothelin Receptor Antagonists; Endothelins; Losartan; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury; Statistics, Nonparametric; Sulfonamides; Testis | 2012 |